{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:28:01Z","timestamp":1779352081527,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T00:00:00Z","timestamp":1113436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00213-005-2250-2","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T19:09:40Z","timestamp":1113419380000},"page":"401-406","source":"Crossref","is-referenced-by-count":35,"title":["Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism"],"prefix":"10.1007","volume":"181","author":[{"given":"Jose J.","family":"Mateos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Lome\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emili","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Prats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,14]]},"reference":[{"key":"2250_CR1","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th ed). Washington, USA"},{"key":"2250_CR2","volume-title":"Dementia praecox or the group of schizophrenias","author":"E Bleuler","year":"1950","unstructured":"Bleuler E (1950) Dementia praecox or the group of schizophrenias. International University Press, New York"},{"key":"2250_CR3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002590050374","volume":"26","author":"J Booij","year":"1999","unstructured":"Booij J, Tissingh G, Winogrodzca A, Van Royen EA (1999) Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 26:171\u2013182","journal-title":"Eur J Nucl Med"},{"key":"2250_CR4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.43.3_Part_1.552","volume":"43","author":"DJ Burn","year":"1993","unstructured":"Burn DJ, Brooks DJ (1993) Nigral dysfunction in drug-induced parkinsonism: an 18F-DOPA PET study. Neurology 43:552\u2013556","journal-title":"Neurology"},{"key":"2250_CR5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1176\/ajp.150.9.1343","volume":"150","author":"M Caliguri","year":"1993","unstructured":"Caliguri M, Lohr J, Jeste D (1993) Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry 150:1343\u20131348","journal-title":"Am J Psychiatry"},{"key":"2250_CR6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","volume":"19","author":"A Catafau","year":"2004","unstructured":"Catafau A, Tolosa E (2004) Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes. Mov Disord 19:1175\u20131182","journal-title":"Mov Disord"},{"key":"2250_CR7","first-page":"1203","volume":"41","author":"PW Corrigan","year":"1990","unstructured":"Corrigan PW, Liberman RP, Engel JD (1990) From noncompliance to collaboration in the treatment of schizophrenia. Hosp Community Psychiatry 41:1203\u20131211","journal-title":"Hosp Community Psychiatry"},{"key":"2250_CR8","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998","volume":"18","author":"M Ernst","year":"1998","unstructured":"Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM (1998) DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomography study. J Neurosci 18:5901\u20135907","journal-title":"J Neurosci"},{"key":"2250_CR9","volume-title":"Structured clinical interview for DSM-IV\u2014patients edition (SCID-P)","author":"MB First","year":"1994","unstructured":"First MB, Spitzer RL, Williams JBW, Gibbon M (1994) Structured clinical interview for DSM-IV\u2014patients edition (SCID-P). American Psychiatric Press, Washington, DC"},{"key":"2250_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(95)00770-9","volume":"298","author":"I Gordon","year":"1996","unstructured":"Gordon I, Weizman R, Rehavi M (1996) Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. Eur J Pharmacol 298:27\u201330","journal-title":"Eur J Pharmacol"},{"key":"2250_CR11","unstructured":"Guy W (1976) Early clinical drug evaluation unit (ECDEU), National Institute of Mental Health 76:338. Rockville, USA"},{"key":"2250_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3956(98)00023-5","volume":"32","author":"MD Jibson","year":"1998","unstructured":"Jibson MD, Tandon R (1998) New atypical antipsychotic medications. J Psychiatry Res 32:215\u2013228","journal-title":"J Psychiatry Res"},{"key":"2250_CR13","first-page":"262","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fisbein S, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:262\u2013273","journal-title":"Schizophr Bull"},{"key":"2250_CR14","volume-title":"Dementia praecox and paraphrenia","author":"E Kraeplin","year":"1919","unstructured":"Kraeplin E (1919) Dementia praecox and paraphrenia. University of Edinburgh, Edinburgh"},{"key":"2250_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/appi.ajp.157.2.269","volume":"157","author":"A Laakso","year":"2000","unstructured":"Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, R\u00e4kk\u00f6l\u00e4inen V, Syv\u00e4lahti E, Hietala J (2000) Striatal dopamine transporter binding in neuroleptic na\u00efve patients with schizophrenia studied with PET. Am J Psychiatry 157:269\u2013271","journal-title":"Am J Psychiatry"},{"key":"2250_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","volume":"52","author":"A Laakso","year":"2001","unstructured":"Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Siv\u00e4lahti E, Hietala J (2001) Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res 52:115\u2013120","journal-title":"Schizophr Res"},{"key":"2250_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-3223(99)00257-7","volume":"47","author":"M Laruelle","year":"2000","unstructured":"Laruelle M, Abi-Dargham A, Van Dyck C, Gil R, D\u2019Souza D, Krystal J, Seibyl J, Baldwin R, Innis R (2000) Dopamine and serotonin transporter in patients with schizophrenia: an imaging study with 123I-\u03b2CIT. Biol Psychiatry 47:371\u2013379","journal-title":"Biol Psychiatry"},{"key":"2250_CR18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","volume":"27","author":"J Lavalaye","year":"2000","unstructured":"Lavalaye J, Booij J, Reneman L, Habraken J, Van Royen E (2000) Effect of age and gender on dopamine transporter imaging with [123I] FP-CIT SPECT in healthy volunteers. Eur J Nucl Med 27:867\u2013869","journal-title":"Eur J Nucl Med"},{"key":"2250_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-9964(00)00023-2","volume":"47","author":"J Lavalaye","year":"2001","unstructured":"Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken J, Gersons B, Van Royen E (2001) Dopamine transporter density in young patients with schizophrenia assessed with [123I] FP-CIT SPECT. Schizophr Res 47:59\u201367","journal-title":"Schizophr Res"},{"key":"2250_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/schbul\/16.1.97","volume":"16","author":"JA Lieberman","year":"1990","unstructured":"Lieberman JA, Kinon BL, Loebel AD (1990) Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 16:97\u2013110","journal-title":"Schizophr Bull"},{"key":"2250_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.168.2.221","volume":"168","author":"RG McCreadie","year":"1996","unstructured":"McCreadie RG, Thara R, Kamath D, Padmavati R, Latha S, Mathrubootham N, Menon S (1996) Abnormal movements in never medicated Indian patients with schizophrenia. Br J Psychiatry 168:221\u2013226","journal-title":"Br J Psychiatry"},{"key":"2250_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.181.4.321","volume":"181","author":"R McCreadie","year":"2002","unstructured":"McCreadie R, Padmavati R, Thara R, Srinivasan TN (2002) Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br J Psychiatry 181:135\u2013137","journal-title":"Br J Psychiatry"},{"key":"2250_CR23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00007611-199005000-00011","volume":"83","author":"LG Miller","year":"1990","unstructured":"Miller LG, Jankovic J (1990) Neuroleptic approach to drug-induced movement disorders: a study of 125 patients. South Med J 83:525\u2013532","journal-title":"South Med J"},{"key":"2250_CR24","first-page":"269","volume":"4","author":"V Peralta","year":"2002","unstructured":"Peralta V, Cuesta M, Campos MS (2002) Sintomas extrapiramidales en pacientes esquizofr\u00e9nicos nunca tratados con neurol\u00e9pticos. Aula M\u00e9d Psiqui\u00e1tr 4:269\u2013280","journal-title":"Aula M\u00e9d Psiqui\u00e1tr"},{"key":"2250_CR25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archneur.1982.00510220042009","volume":"10","author":"AH Rajput","year":"1982","unstructured":"Rajput AH, Rozdilsky B, Hornykiewicz O, Shannak K, Lee T, Seeman P (1982) Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol 10:644\u2013646","journal-title":"Arch Neurol"},{"key":"2250_CR26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1022405621365","volume":"23","author":"TA Reader","year":"1998","unstructured":"Reader TA, Ase AR, Huang N, Hebert C, Van Gelder NM (1998) Neuroleptics and dopamine transporters. Neurochem Res 23:73\u201380","journal-title":"Neurochem Res"},{"key":"2250_CR27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(84)90403-5","volume":"104","author":"E Richelson","year":"1984","unstructured":"Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277\u2013286","journal-title":"Eur J Pharmacol"},{"key":"2250_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(95)00611-S","volume":"692","author":"R Rivest","year":"1995","unstructured":"Rivest R, Falardeau P, Di Paolo T (1995) Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 692:269\u2013272","journal-title":"Brain Res"},{"key":"2250_CR29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1176\/ajp.154.12.1641","volume":"154","author":"MV Seeman","year":"1997","unstructured":"Seeman MV (1997) Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154:1641\u20131647","journal-title":"Am J Psychiatry"},{"key":"2250_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JW (1970) A rating scale for extra-pyramidal side effects. Acta Psychiatr Scand, Suppl 212:11\u201319","journal-title":"Acta Psychiatr Scand, Suppl"},{"key":"2250_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-003-1700-y","volume":"173","author":"H Sjoholm","year":"2004","unstructured":"Sjoholm H, Bratlid T, Sundsfjord J (2004) 123I \u03b2-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia. Psychopharmacology 173:27\u201331","journal-title":"Psychopharmacology"},{"key":"2250_CR32","first-page":"31","volume":"40","author":"K Tatsch","year":"1999","unstructured":"Tatsch K, Scherer J, Linke R, Kerner M, Hahn K (1999) Decrease of dopamine transporter binding in neuroleptic-free schizophrenic patients assessed with IPT-SPECT (abstr.) J Nucl Med 40:31","journal-title":"J Nucl Med"},{"key":"2250_CR33","first-page":"1143","volume":"39","author":"G Tissingh","year":"1998","unstructured":"Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, Van Royen EA, Stoof JC, Wolters E (1998) Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-ebeta-(4-iodophenyl)-tropane SPECT in healthy controls and early-stage, drug-na\u00efve Parkinson\u2019s disease. J Nucl Med 39:1143\u20131148","journal-title":"J Nucl Med"},{"key":"2250_CR34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-4159.1993.tb03174.x","volume":"60","author":"M Valchar","year":"1993","unstructured":"Valchar M, Hanbauer I (1993) Comparison of 3HWIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats. J Neurochem 60:469\u2013476","journal-title":"J Neurochem"},{"key":"2250_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-2999(95)00594-3","volume":"294","author":"T Vander","year":"1995","unstructured":"Vander T, Kilbourn M, Desmond T, Kuhl D, Frey K (1995) The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 294:577\u2013583","journal-title":"Eur J Pharmacol"},{"key":"2250_CR36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130051163","volume":"147","author":"NPLG Verhoeff","year":"1999","unstructured":"Verhoeff NPLG (1999) Radiotracers imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology 147:217\u2013249","journal-title":"Psychopharmacology"},{"key":"2250_CR37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","volume":"73","author":"Z Walker","year":"2002","unstructured":"Walker Z, Costa DC, Walker RWH, Shaw K, Gacinovic S, Stevens T, Livingston G, Ince P, McKeith IG, Katona CLE (2002) Differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 73:134\u2013140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2250_CR38","first-page":"304","volume":"24","author":"A Wolff","year":"1999","unstructured":"Wolff A, O\u2019Driscoll G (1999) Motor deficits and schizophrenia: the evidence from neuroleptic-na\u00efve patients and populations at risk. J Psychiatry Neurosci 24:304\u2013314","journal-title":"J Psychiatry Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2250-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-2250-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2250-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:17Z","timestamp":1558629077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-2250-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,14]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-2250-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,14]]}}}